The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for C Di Giovanni


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening.EBI
University of Naples Federico Ii
Structural development studies of PPARs ligands based on tyrosine scaffold.EBI
Universit£&Quot;G. D'Annunzio&Quot
Identification of a new series of amides as non-covalent proteasome inhibitors.EBI
University of Messina
Development of peptidomimetic boronates as proteasome inhibitors.EBI
University of Messina
New 2-(aryloxy)-3-phenylpropanoic acids as peroxisome proliferator-activated receptora/¿ dual agonists able to upregulate mitochondrial carnitine shuttle system gene expression.EBI
Universit�
Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activity.EBI
Istituto Tumori&Quot;Giovanni Paolo Ii&Quot
Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening.EBI
University of Naples Federico II
Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptorsa/¿ dual agonists.EBI
University of Bari Aldo Moro
Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, and biological activities.EBI
Fondazione Cenci Bolognettiuniversit£